Product
Insulin Glargine + Lixisenatide
Aliases
Insulin glargine/Lixisenatide
2 clinical trials
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
A Randomized, 24 Weeks, Active-controlled, Open-label, 2-arm Multicenter Study Comparing the Efficacy and Safety of iGlarLixi to IDegAsp in Chinese Type 2 Diabetes Mellitus Participants Insufficiently Controlled With Oral Antidiabetic Drug(s)Status: Completed, Estimated PCD: 2023-10-20
Clinical trial
A 16-week, Multicenter, Prospective, Open-label, Single-arm, Phase 4 Study to Evaluate the Effect of Soliqua™ 100/33 on the Percentage of Time in Range (TIR) From Continuous Glucose Monitoring (CGM) in Insulin-naïve Patients With Very Uncontrolled Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2023-03-28